Olorofim in combination with azole antifungals: results from the Phase 2 salvage therapy study.

Maertens J, Chen SCA, Thompson GR, Donovan F, Dane A, Birch M, Pinder C, Bennett J, Ravenna V, Marin Fernandez O, Ross G, Zinzi D, Rex JH, Phase 2b Olorofim Salvage Therapy Study Group .

Open source

DOI: 10.1093/jac/dkag118
Published: 2026-03-01
Container: J Antimicrob Chemother
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jac/dkag118,
  title = {Olorofim in combination with azole antifungals: results from the Phase 2 salvage therapy study.},
  author = {Maertens J and  Chen SCA and  Thompson GR and  Donovan F and  Dane A and  Birch M and  Pinder C and  Bennett J and  Ravenna V and  Marin Fernandez O and  Ross G and  Zinzi D and  Rex JH and  Phase 2b Olorofim Salvage Therapy Study Group
.},
  year = {2026},
  journal = {J Antimicrob Chemother},
  doi = {10.1093/jac/dkag118},
  url = {https://doi.org/10.1093/jac/dkag118}
}

RIS

TY  - JOUR
TI  - Olorofim in combination with azole antifungals: results from the Phase 2 salvage therapy study.
AU  - Maertens J
AU  -  Chen SCA
AU  -  Thompson GR
AU  -  Donovan F
AU  -  Dane A
AU  -  Birch M
AU  -  Pinder C
AU  -  Bennett J
AU  -  Ravenna V
AU  -  Marin Fernandez O
AU  -  Ross G
AU  -  Zinzi D
AU  -  Rex JH
AU  -  Phase 2b Olorofim Salvage Therapy Study Group
.
PY  - 2026
JO  - J Antimicrob Chemother
DO  - 10.1093/jac/dkag118
UR  - https://doi.org/10.1093/jac/dkag118
ER  -

APA

J, M., SCA, C., GR, T., F, D., A, D., M, B., C, P., J, B., V, R., O, M. F., G, R., D, Z., JH, R., & ., P. 2. O. S. T. S. G. (2026). Olorofim in combination with azole antifungals: results from the Phase 2 salvage therapy study.. J Antimicrob Chemother. https://doi.org/10.1093/jac/dkag118

Source records

europe-pmc · retrieved 2026-09-25T22:20:38.781Z